Simplex Trading
SRPT icon

Simplex Trading’s Sarepta Therapeutics SRPT Stock Holding History

Simplex Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63,784
Closed -$8.82M – 9531
2024
Q2 		$10.1M Sell
63,784
-2,996
-4% -$385K 0.01% 1011
2024
Q1 		$8.64M Buy
66,780
+34,561
+107% +$4.23M 0.01% 1221
2023
Q4 		$3.11M Buy
32,219
+8,660
+37% +$831K ﹤0.01% 1977
2023
Q3 		$2.85M Sell
23,559
-12,276
-34% -$1.39M ﹤0.01% 1783
2023
Q2 		$4.1M Buy
+35,835
New +$4.62M ﹤0.01% 1446
2022
Q1 		– Sell
-16,443
Closed -$1.26M – 11343
2021
Q4 		$1.48M Sell
16,443
-2,268
-12% -$194K ﹤0.01% 2369
2021
Q3 		$1.46M Sell
18,711
-90
-0.5% -$6.93K ﹤0.01% 2571
2021
Q2 		$1.46M Sell
18,801
-14,554
-44% -$1.1M ﹤0.01% 2601
2021
Q1 		$0 Buy
+33,355
New +$3.08M ﹤0.01% 9960
2020
Q4 		– Sell
-290
Closed -$43K – 9048
2020
Q3 		$40K Buy
290
+200
+222% +$30.4K ﹤0.01% 5830
2020
Q2 		$14K Hold
90
– – ﹤0.01% 6460
2020
Q1 		$8K Sell
90
-28,107
-100% -$3.21M ﹤0.01% 6620
2019
Q4 		$3.64M Buy
+28,197
New +$2.85M 0.01% 1004
2019
Q3 		– Sell
-18,090
Closed -$2.14M – 7858
2019
Q2 		$2.75M Buy
18,090
+8,913
+97% +$1.08M 0.01% 1064
2019
Q1 		$1.09M Buy
9,177
+2,997
+48% +$385K ﹤0.01% 1916
2018
Q4 		$674K Sell
6,180
-3,905
-39% -$488K ﹤0.01% 1957
2018
Q3 		$1.63M Sell
10,085
-6,835
-40% -$934K 0.01% 1421
2018
Q2 		$2.24M Sell
16,920
-459
-3% -$43.3K 0.01% 1057
2018
Q1 		$1.29M Sell
17,379
-820
-5% -$54.7K 0.06% 304
2017
Q4 		$1.01M Sell
18,199
-28,197
-61% -$1.49M 0.04% 399
2017
Q3 		$2.1M Buy
46,396
+26,356
+132% +$1.05M 0.09% 177
2017
Q2 		$675K Sell
20,040
-27,441
-58% -$893K 0.03% 515
2017
Q1 		$1.41M Buy
+47,481
New +$1.47M 0.06% 287
2016
Q3 		– Sell
-34,308
Closed -$1.04M – 6420
2016
Q2 		$654K Buy
34,308
+4,259
+14% +$78.9K 0.04% 423
2016
Q1 		$586K Buy
30,049
+4,273
+17% +$74.7K 0.05% 386
2015
Q4 		$994K Buy
25,776
+13,215
+105% +$428K 0.08% 217
2015
Q3 		$403K Buy
12,561
+3,563
+40% +$121K 0.03% 530
2015
Q2 		$273K Sell
8,998
-9,580
-52% -$196K 0.02% 646
2015
Q1 		$246K Sell
18,578
-10,453
-36% -$139K 0.03% 625
2014
Q4 		$420K Buy
+29,031
New +$492K 0.05% 326

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's SRPT Position: Q3 2024 in Review

Simplex Trading sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 63,784 shares — an estimated $8.82M sold.

Simplex Trading first reported a position in SRPT in Q4 2014 and held it in 30 quarters. The position peaked at $10.1M in Q2 2024. 458 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

  • Simplex Trading reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 63,784 Sarepta Therapeutics shares in Q3 2024, an estimated $8.82M.
  • Simplex Trading first reported a position in Sarepta Therapeutics in Q4 2014 and held it in 30 quarters.
  • Simplex Trading's Sarepta Therapeutics position peaked at $10.1M in Q2 2024.
  • 458 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.